Skip to main content
. 2014 Apr 4;2(3):58–63. doi: 10.1002/nmi2.40

Table 2.

Susceptibility of KPC-producing Klebsiella pneumoniae isolates

Vitek MIC μg mL−1 to:
E-test MIC μg mL−1 to:
K. pneumoniae isolate TZP FOX CTX CAZ CEP GEM ANK CIP COL IPM MEM IPM MEM TYG COL
A1 ≥128/4 ≥64 16 16 8 ≥16 16 ≥4 ≥16 8 4 8 4 2 24
A2 ≥128/4 ≥64 16 16 8 ≥16 16 ≥4 ≥16 8 4 8 4 2 24
B1 ≥128/4 ≥64 16 16 8 ≥16a 32 ≥4 ≥16 ≥16 4 8 8 2 24
B2 ≥128/4 ≥64 16 16 8 ≥16 32 ≥4 ≥16 ≥16 4 8 8 2 24
B3 ≥128/4 ≥64 16 16 8 ≥16 32 ≥4 ≥16 ≥16 4 8 8 2 24
B5 ≥128/4 ≥64 16 32 8 ≥16 32 ≥4 ≥16 ≥16 8 16 8 2 24
B6 ≥128/4 ≥64 ≥64 ≥64 ≥64 ≥16b ≥64 ≥4 ≥16 ≥16 ≥16 ≥32 ≥32c 2 24

PTZ, piperacillin-tazobactam; FOX, cefoxitin; CTX, cefotaxime; CAZ, ceftazidime; CEP, cefepime; GEM, gentamicin; ANK, amikacin; CIP, ciprofloxacin; COL, colistin; IPM, imipenem; MEM, meropenem; TYG, tigecycline.

a

E-test MIC 36 μg/mL.

b

E-test MIC 96 μg/mL.

c

E-test MIC 256 μg/mL.